None of the antitumor agents in the CCLE-GDSC dataset had their response associated with PHLDA2 copy number, suggesting that the associations of drug response with expression of this gene in tumor cells may be influenced by its transcriptional regulation rather than by copy number changes. Here, PHLDA2 is linked to neoplasm.